A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ARMS / alveolar RMS

[Related PubMed/MEDLINE]
Total Number of Papers: 57
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ARMS  (>> Co-occurring Abbreviation)
Long Form:   alveolar RMS
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Bis-indole derived nuclear receptor 4A1 (NR4A1) antagonists inhibit TGFbeta-induced invasion of embryonal rhabdomyosarcoma cells. ERMS, IL-24, NR4A1, RMS, TGF-beta
2020 Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee. ERMS, OS, RMS, RT, SRMS
2020 The IRE1 and PERK arms of the unfolded protein response promote survival of rhabdomyosarcoma cells. ER, ERMS, RMS, UPR
2020 Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib. JAK, OV, RMS
2019 Primary Rhabdomyosarcoma of the Breast: Study of Three Cases at One Institution with a Review of Primary Breast Sarcomas. ERMS, PBS, RMS, ssRMS
2019 Proteomic Profiling of Rhabdomyosarcoma-Derived Exosomes Yield Insights into Their Functional Role in Paracrine Signaling. ERMS, RMS
2018 Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. EFS, ERMS, RMS, VAC
2018 Clinical and Cytogenetic Profiles of Rhabdomyosarcoma with Bone Marrow Involvement in Korean Children: A 15-Year Single-Institution Experience. ERMS, OS, RMS
2018 Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience. DFS, ERMS, IHC, OS, RMSs
10  2018 EGR1 interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma. ERMS, RMS
11  2018 Pannexin 1 inhibits rhabdomyosarcoma progression through a mechanism independent of its canonical channel function. PANX1, RMS
12  2018 The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma. HDAC, RMS
13  2017 18F-FDG PET/CT is useful in initial staging, restaging for pediatric rhabdomyosarcoma. 18F-FDG, CT, MRI, PET, RMS
14  2017 Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA. PKM, PTBP1, RMS
15  2017 NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma. ERMS, RMS, RRBS
16  2016 FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target. ERMS, FOXM1, RMS, siRNA, VEGF
17  2016 Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma. RMS
18  2016 Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma. ERMS, IRS, RMS
19  2016 Inhibitory Effects of Resveratrol on the Human Alveolar Rhabdomyosarcoma Cell Line PLA-802 through Inhibition of the TGF-beta1/Smad Signaling Pathway. RMS
20  2016 [Analysis of 13 cases of rhabdomyosarcoma in the female genital tract]. ERMS, FIGO, IRSG, RMS
21  2015 Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition. ALK, IGF1R, RMS, ROS
22  2015 Hedgehog Inhibitors in Rhabdomyosarcoma: A Comparison of Four Compounds and Responsiveness of Four Cell Lines. HH/SMO, RMS
23  2015 MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA. ERMS, miRNAs, RARA, RMS, RXRA
24  2014 Compound HRAS/PIK3CA mutations in Chinese patients with alveolar rhabdomyosarcomas. RMS
25  2014 Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas. CT, ERMS, FISH, RMS
26  2014 Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study. ALK, ERMS, FISH, IHC, OS, RMS
27  2013 Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells. DN, RMS
28  2013 Dynamic and nuclear expression of PDGFRalpha and IGF-1R in alveolar Rhabdomyosarcoma. FACS, IGF, PDGFR, RMS, RTK
29  2013 ESF-EMBO Symposium "Molecular Biology and Innovative Therapies in Sarcomas of Childhood and Adolescence" Sept 29-Oct 4, Polonia Castle Pultusk, Poland. ES, RMS, TF
30  2013 Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma. DAPK1, ERMS, GREM1, HEY1, MYOD1, P3F, RMS
31  2013 Mechanisms of impaired differentiation in rhabdomyosarcoma. ERMS, RMS
32  2013 Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice. ALK, ERMS, IGF-1R, RMS
33  2012 Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications. ALK, ERMS, RMS
34  2012 Detection of PAX3/PAX7-FKHR fusion transcripts in rhabdomyosarcoma and other small round cell tumors by 1-step reverse transcriptase polymerase chain reaction: a novel tool for diagnosis and differentiation. ERMS, RMS, SRCTs
35  2012 FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma. ERMS, FGFR4, RMS, RTK, shRNA
36  2012 RasGRF1 regulates proliferation and metastatic behavior of human alveolar rhabdomyosarcomas. ERMS, RMS
37  2012 [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases]. ERMS, PdRMS, PRMS, RMS
38  2010 Detection of fusion genes in formalin-fixed paraffin-embedded tissue sections of rhabdomyosarcoma by RT-PCR and fluorescence in situ hybridization in Mexican patients. ERMS, FFPET, FISH, RMS
39  2009 ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status. ALK, ERMS, FISH, RMS, URMS
40  2009 Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors. ERMS, IGF, IGF1R, IGF2R, IGFBP-2, RMS
41  2009 MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53. ERMS, RMS
42  2008 Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype. ERMS, LI, pRB, RMS
43  2008 Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma. BCRP, ERMS, LI, MDR, MVP, P-gp, RMS, YB-1
44  2007 Embryonal rhabdomyosarcoma with a der(16)t(1;16) translocation. ERMS
45  2007 Molecular biology of rhabdomyosarcoma. ERMS, RMS
46  2007 Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK). ILK, ILK, RMS, uPA
47  2006 An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience. ERMS, RMS
48  2006 Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. ERMS, FFS, IRS, RMS, UDS
49  2006 Differentiation of rhabdomyosarcoma cell lines using retinoic acid. APML, ATRA, CRA, RA, RMS
50  2005 FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma. ERMS, RMS
51  2005 Multimodal genetic diagnosis of solid variant alveolar rhabdomyosarcoma. CGH, ERMS, RMS, RT-PCR
52  2004 A novel t(2;20)(q35;p12) in embryonal rhabdomyosarcoma. ERMS, RMS
53  2004 Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. ERMS, RMS
54  2004 Variation in cadherins and catenins expression is linked to both proliferation and transformation of Rhabdomyosarcoma. ERMS, RMS
55  2001 Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. ERMSs, RMS
56  2000 Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues. ERMS, ES, FFPE, RMS
57  1998 [Evidence of genetic alterations in chromosome 11 in embryonal and alveolar rhabdomyosarcoma]. CGH, ERMS, RMS